novo nordisk's semaglutide failed to slow alzheimer's disease progression in early-stage Drug maker Novo Nordisk has

Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals

Bottom line: GLP-1s are powerful, but nutrition and lifestyle are the true amplifiers that make outcomes healthier, more sustainable, and more cost-effective

Pasqualotto FF, Sundaram A, Sharma RK, Borges E Jr, Pasqualotto EB, Agarwal A

Always use them under the supervision of a healthcare professional

Data in ATTAIN-MAINTAIN after rescue orforglipron were imputed with worst value observed prior to start of rescue

According to the company's providers page, their clinical team includes board-certified obesity specialists and nurse practitioners